These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23856040)

  • 21. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy: A. R. Rastinehad, B. Turkbey, S. S. Salami, O. Yaskiv, A. K. George, M. Fakhoury, K. Beecher, M. A. Vira, L. R. Kavoussi, D. N. Siegel, R. Villani and E. Ben-Levi. J Urol 2014; 191: 1749-1754.
    Patodia M; Goel A; Kumar M
    J Urol; 2014 Dec; 192(6):1888; discussion 1888-9. PubMed ID: 25194541
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reply from Authors re: Riccardo Bartoletti, Tommaso Cai. Prostate Biopsies Should Be Performed According to a Standard of Care. Eur Urol 2013;63:528-9.
    Wagenlehner F; van Oostrum E; Tenke P; Tandogdu Z; Cek M; Grabe M; Wullt B; Pickard R; Naber KG; Pilatz A; Weidner W; Bjerklund-Johansen TE
    Eur Urol; 2013 Mar; 63(3):529-30. PubMed ID: 22868669
    [No Abstract]   [Full Text] [Related]  

  • 25. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
    Kamrava M; Hegde JV; Abgaryan N; Chang E; Le JD; Wang J; Kupelian PA; Marks LS
    BJU Int; 2016 Apr; 117(4):584-91. PubMed ID: 25684394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
    Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
    Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-targeted biopsies: What's next?
    Ploussard G; Briganti A
    World J Urol; 2019 Feb; 37(2):219-220. PubMed ID: 30712090
    [No Abstract]   [Full Text] [Related]  

  • 30. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
    Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
    BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Thomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 2012;61:177-84.
    Ponholzer A; Madersbacher S
    Eur Urol; 2012 May; 61(5):e52. PubMed ID: 22365282
    [No Abstract]   [Full Text] [Related]  

  • 35. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
    Albisinni S; Aoun F; Noel A; El Rassy E; Lemort M; Paesmans M; van Velthoven R; Roumeguère T; Peltier A
    Prog Urol; 2018 Jan; 28(1):18-24. PubMed ID: 29203158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
    Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
    World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-9.
    Pokorny M; Van de Ven W; Barentsz J; Thompson L
    Eur Urol; 2015 Mar; 67(3):e54-5. PubMed ID: 25194908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.